Overview
Announcements

Ordinary Index Rebalancing in the North American Psychedelics Index | 19th December 2022

In the ordinary rebalance the following composition will be implemented over the period starting at cob 15.12.2022 and ending at cob 16.12.2022. The final index composition will be effective at the open 19.12.2022.

ABBVIE INC
ATAI LIFE SCIENCES B.V
COMPASS PATHWAYS PLC
CYBIN INC
GH RESEARCH PLC
GREENBROOK TMS INC
JOHNSON & JOHNSON
MIND MEDICINE MINDMED INC
MINDSET PHARMA INC
NUMINUS WELLNESS INC
RELMADA THERAPEUTICS INC.
REVIVE THERAPEUTICS LTD
SEELOS THERAPEUTICS INC
FSD PHARMA INC-CLASS B
CORE ONE LABS INC